Vyvanse 50 mg/1
LISDEXAMFETAMINE DIMESYLATE · TABLET, CHEWABLE · Takeda Pharmaceuticals America, Inc.
Vyvanse is a tablet, chewable containing lisdexamfetamine dimesylate at 50 mg/1, taken oral. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Vyvanse
- Generic Name
- LISDEXAMFETAMINE DIMESYLATE
- NDC Code (Product)
59417-119- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 50 mg/1
- Dosage Form
- TABLET, CHEWABLE
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- NDA208510
- Marketing Start
- 01/28/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Vyvanse used for?
Vyvanse contains LISDEXAMFETAMINE DIMESYLATE. It is a tablet, chewable taken oral. Consult your doctor for specific uses.
Is Vyvanse a controlled substance?
Yes, Vyvanse is classified as CII under the DEA Controlled Substances Act.
What is the generic name for Vyvanse?
The generic name for Vyvanse is LISDEXAMFETAMINE DIMESYLATE. There are 10 other brand versions of LISDEXAMFETAMINE DIMESYLATE.
What is the NDC code for Vyvanse 50 mg/1?
The NDC (National Drug Code) for Vyvanse 50 mg/1 is 59417-119, listed by Takeda Pharmaceuticals America, Inc..
Other Vyvanse Dosages
Other Lisdexamfetamine Brands
See all →- LISDEXAMFETAMINE DIMESYLATE10 mg/172162-2451
- LISDEXAMFETAMINE DIMESYLATE30 mg/172162-2454
- Lisdexamfetamine dimesylate30 mg/172205-134
- Lisdexamfetamine dimesylate20 mg/10480-3566
- lisdexamfetamine dimesylate60 mg/10480-9744
- LISDEXAMFETAMINE DIMESYLATE60 mg/131722-326
- LISDEXAMFETAMINE DIMESYLATE40 mg/142858-164
- Lisdexamfetamine dimesylate10 mg/143547-602
- Lisdexamfetamine dimesylate50 mg/143547-606
- Lisdexamfetamine Dimesylate60 mg/160505-4744
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)